 |
인쇄하기
취소
|
KIT to conduct large-scale preclinical tests over antisense oligonucleotides
The Korea Institute of Toxicology (KIT) said on March 16 that KIT will carry out its preclinical studies for the US based ISIS Pharmaceuticals Inc’s antisense oligonucleotides (ASO) using non-human primates.
Both organizations signed a memorandum of understanding (MOU) about the (ASO) based preclinical studies.
The KIT will cooperate with the foreign pharmaceutical firm in developing new ...
Both organizations signed a memorandum of understanding (MOU) about the (ASO) based preclinical studies.
The KIT will cooperate with the foreign pharmaceutical firm in developing new ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.